Spruce Street Capital LP - 31 Dec 2025 SCHEDULE 13G Report for RELMADA THERAPEUTICS, INC. Common Stock, par value $0.001 per share (RLMD)

Filing Manager
Spruce Street Capital LP
Reporting Manager
Spruce Street Capital LP
Security
RELMADA THERAPEUTICS, INC. Common Stock, par value $0.001 per share
Symbol
RLMD
Shares outstanding
73,360,521 shares
Disclosed Ownership
4,086,181 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
17 Feb 2026, 09:15:23 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Spruce Street Capital LP 5.6% 4,086,181 0 4,086,181 /s/ Alex R. Rosen By: Spruce Street Capital GP LLC, its General Partner, By: Alex R. Rosen, its Co-Managing Member
Alex R. Rosen 5.6% 4,086,181 0 4,086,181 /s/ Alex R. Rosen Alex R. Rosen, individually
Simon Basseyn 5.6% 4,086,181 0 4,086,181 /s/ Simon Basseyn Simon Basseyn, individually